Literature DB >> 6986826

Norepinephrine innervation of the cochlear nuclei by locus coeruleus neurons in the rat.

L F Kromer, R Y Moore.   

Abstract

The cochlear nuclei (CN) contain a moderate concentration of norepinephrine (445 +/- 20 ng/g tissue) with dopamine levels (46 +/- 14 ng/g) that are low and within the precursor range expected for a norepinephrine (NE) terminal system. Lesion and horseradish peroxidase (HRP) experiments indicate that this innervation is bilateral and arises from fusiform and multipolar neurons in the locus coeruleus. Autoradiographic and fluorescence histochemical experiments demonstate that locus coeruleus fibers reach the ipsilateral ventral cochlear nuclei via a rostral pathway that projects from the rostral locus coeruleus laterally through the brain stem to the rostral tip of the ventral nuclei. This pathway is located dorsal to the motor and spinal trigeminal nuclei and ventral to the middle cerebellar peduncle. Descending coeruleo-cochlear fibers travel between the fourth ventricle and the vestibular nuclei to enter the acoustic striae. These fibers innervate both the dorsal and ventral nuclei. Contralateral locus fibers reach the CN by crossing in the pontine central gray at the rostral border of the fourth ventricle and by decussating with the fibers of the mesencephalic trigeminal nucleus ventral to the medial longitudinal fasciculus. The bilateral locus coeruleus innervation of the cochlear nuclei comprises a highly collateralized network of varicose axons which are not topographically organized. Unlike the cochlear nerve fibers in the CN which form specific projections, the locus coeruleus afferents to these sensory nuclei are diffuse and non-specific.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6986826     DOI: 10.1007/BF00315908

Source DB:  PubMed          Journal:  Anat Embryol (Berl)        ISSN: 0340-2061


  29 in total

1.  THE ANTERIOR VENTRAL COCHLEAR NUCLEUS.

Authors:  J M HARRISON; R IRVING
Journal:  J Comp Neurol       Date:  1965-02       Impact factor: 3.215

2.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. II. EXPERIMENTALLY INDUCED CHANGES IN THE INTRANEURONAL AMINE LEVELS OF BULBOSPINAL NEURON SYSTEMS.

Authors:  A DAHLSTROEM; K FUXE
Journal:  Acta Physiol Scand Suppl       Date:  1965

3.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. IV. DISTRIBUTION OF MONOAMINE NERVE TERMINALS IN THE CENTRAL NERVOUS SYSTEM.

Authors:  K FUXE
Journal:  Acta Physiol Scand Suppl       Date:  1965

4.  The identification of thalamocortical relay cells in the adult cat by means of retrograde axonal transport of horseradish peroxidase.

Authors:  H J Ralston; P V Sharp
Journal:  Brain Res       Date:  1973-11-09       Impact factor: 3.252

5.  Stereotaxic mapping of the monoamine pathways in the rat brain.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

6.  On the projections from the locus coeruleus noradrealine neurons: the cerebellar innervation.

Authors:  L Olson; K Fuxe
Journal:  Brain Res       Date:  1971-04-16       Impact factor: 3.252

7.  The adrenergic innervation of the rat thalamus as revealed by the glyoxylic acid fluorescence method.

Authors:  O Lindvall; A Björklund; A Nobin; U Stenevi
Journal:  J Comp Neurol       Date:  1974-04-01       Impact factor: 3.215

8.  Catecholamines in fetal and newborn rat brain.

Authors:  J T Coyle; D Henry
Journal:  J Neurochem       Date:  1973-07       Impact factor: 5.372

9.  A study of the organization of the locus coeruleus projections to the lateral geniculate nuclei in the albino rat.

Authors:  L F Kromer; R Y Moore
Journal:  Neuroscience       Date:  1980       Impact factor: 3.590

10.  The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique.

Authors:  R C Graham; M J Karnovsky
Journal:  J Histochem Cytochem       Date:  1966-04       Impact factor: 2.479

View more
  7 in total

1.  Amygdalar Gating of Early Sensory Processing through Interactions with Locus Coeruleus.

Authors:  Cynthia D Fast; John P McGann
Journal:  J Neurosci       Date:  2017-02-10       Impact factor: 6.167

2.  Outer Hair Cell Glutamate Signaling through Type II Spiral Ganglion Afferents Activates Neurons in the Cochlear Nucleus in Response to Nondamaging Sounds.

Authors:  Catherine J C Weisz; Sean-Paul G Williams; Chad S Eckard; Christopher B Divito; David W Ferreira; Kristen N Fantetti; Shenin A Dettwyler; Hou-Ming Cai; Maria E Rubio; Karl Kandler; Rebecca P Seal
Journal:  J Neurosci       Date:  2021-02-11       Impact factor: 6.167

3.  Attenuation of noise-induced hyperactivity in the dorsal cochlear nucleus by pre-treatment with MK-801.

Authors:  M W Criddle; D A Godfrey; J A Kaltenbach
Journal:  Brain Res       Date:  2018-01-09       Impact factor: 3.252

4.  Immunohistochemical demonstration of regionally selective projections from locus coeruleus to the vestibular nuclei in rats.

Authors:  R J Schuerger; C D Balaban
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

5.  Mutant mouse tottering: selective increase of locus ceruleus axons in a defined single-locus mutation.

Authors:  P Levitt; J L Noebels
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

6.  Loud Noise Exposure Produces DNA, Neurotransmitter and Morphological Damage within Specific Brain Areas.

Authors:  Giada Frenzilli; Larisa Ryskalin; Michela Ferrucci; Emanuela Cantafora; Silvia Chelazzi; Filippo S Giorgi; Paola Lenzi; Vittoria Scarcelli; Alessandro Frati; Francesca Biagioni; Stefano Gambardella; Alessandra Falleni; Francesco Fornai
Journal:  Front Neuroanat       Date:  2017-06-26       Impact factor: 3.856

7.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.